Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis.
about
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degenerationTreatment of Exudative Age-related Macular Degeneration: Focus on AfliberceptShort-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis.One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement.Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab.Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom.Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series.Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
P2860
Q26771522-D0D69762-BED0-4723-8373-3498F64C4C7CQ26786766-653FEDDA-83C9-46A9-AD5E-611873E77917Q35669341-E819BAF9-EC3E-47A2-80D0-9666B507EFDDQ35947415-61A5700B-9E53-4284-A04F-0138350A9EF7Q36955686-7530395C-30AE-4935-A618-7E1C706E3D72Q38582381-9A85DF23-B637-480E-B1B5-3A8CE2C0822CQ39312232-2DF99EB9-DCEE-4FF9-A5C1-9775EF060EFCQ50453108-1EEDC56A-78D1-4160-8D3B-1F4B06705866Q52944872-9E237480-69FB-4D12-A828-2D13EADB367EQ54171873-FE06A7CD-A079-4874-9CB9-341203616D61Q58694356-57E2161B-7710-40D7-A8CD-F333719F00CF
P2860
Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@en
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@nl
type
label
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@en
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@nl
prefLabel
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@en
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@nl
P2093
P2860
P356
P1476
Intravitreal aflibercept for p ...... ing ranibizumab tachyphylaxis.
@en
P2093
Hiroshi Goto
Masahiro Miura
Takuya Iwasaki
P2860
P304
P356
10.2147/OPTH.S50634
P407
P577
2013-08-07T00:00:00Z